drugset / Trial / NCT00270881

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

NCT00270881 ↗

Phase 1/2 Completed 33 enrolled Keio University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to evaluate the safety and efficacy of cord blood transplantation for adult patients with hematologic malignancies including refractory acute leukemia. The transplant procedure was determined in detail according to the previously published report showing a high survival, so that the investigators could expect a similar result.

Timeline

Start
2006-01
Primary completion
2009-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Background Cyclophosphamide Other / unclassified 120 mg/kg —
Background Cytarabine Small molecule 3 g —